# Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

> **NCT01615874** · PHASE2 · WITHDRAWN · sponsor: **Organon and Co**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MF/F Metered Dose Inhaler (MDI) 25/5 mcg
- **DRUG:** MF/F MDI 50/5 mcg
- **DRUG:** MF/F MDI 100/5 mcg
- **DRUG:** BDP hydrofluoroalkane (HFA) 80 mcg
- **DRUG:** Montelukast tablets 5 mg (4 mg for children 5 years of age)
- **DRUG:** Rescue medication: short-acting beta-2 agonist (SABA) MDI
- **DRUG:** Rescue medication: Prednisone/Prednisolone

## Key facts

- **NCT ID:** NCT01615874
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01615874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01615874, "Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01615874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*